Annexin Pharmaceuticals (Sweden) Buy Hold or Sell Recommendation
| ANNX Stock | SEK 0.50 0.01 1.96% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Annexin Pharmaceuticals AB is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Annexin Pharmaceuticals AB given historical horizon and risk tolerance towards Annexin Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Annexin Pharmaceuticals AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Annexin Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Annexin and provide practical buy, sell, or hold advice based on investors' constraints. Annexin Pharmaceuticals AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Annexin |
Execute Annexin Pharmaceuticals Buy or Sell Advice
The Annexin recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Annexin Pharmaceuticals AB. Macroaxis does not own or have any residual interests in Annexin Pharmaceuticals AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Annexin Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Annexin Pharmaceuticals Trading Alerts and Improvement Suggestions
| Annexin Pharmaceuticals generated a negative expected return over the last 90 days | |
| Annexin Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Annexin Pharmaceuticals has high historical volatility and very poor performance | |
| Annexin Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annexin Pharmaceuticals AB has accumulated about 22.77 M in cash with (45.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 45.0% of the company shares are held by company insiders |
Annexin Pharmaceuticals Returns Distribution Density
The distribution of Annexin Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Annexin Pharmaceuticals' future price movements. The chart of the probability distribution of Annexin Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Annexin Pharmaceuticals AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Annexin Pharmaceuticals returns is essential to provide solid investment advice for Annexin Pharmaceuticals.
| Mean Return | -0.04 | Value At Risk | -6.12 | Potential Upside | 8.33 | Standard Deviation | 4.75 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Annexin Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Annexin Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Annexin Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Annexin Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Annexin stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.08 | |
β | Beta against Dow Jones | 0.27 | |
σ | Overall volatility | 4.74 | |
Ir | Information ratio | -0.04 |
Annexin Pharmaceuticals Volatility Alert
Annexin Pharmaceuticals AB exhibits very low volatility with skewness of 0.91 and kurtosis of 1.34. Annexin Pharmaceuticals AB is a potential penny stock. Although Annexin Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Annexin Pharmaceuticals AB. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Annexin instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Annexin Pharmaceuticals Fundamentals Vs Peers
Comparing Annexin Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Annexin Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Annexin Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Annexin Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Annexin Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Annexin Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Annexin Pharmaceuticals to competition |
| Fundamentals | Annexin Pharmaceuticals | Peer Average |
| Return On Equity | -1.06 | -0.31 |
| Return On Asset | -0.57 | -0.14 |
| Current Valuation | 125.48 M | 16.62 B |
| Shares Outstanding | 154.5 M | 571.82 M |
| Shares Owned By Insiders | 45.17 % | 10.09 % |
| Shares Owned By Institutions | 5.06 % | 39.21 % |
| Price To Book | 4.90 X | 9.51 X |
| EBITDA | (50.28 M) | 3.9 B |
| Net Income | (52.14 M) | 570.98 M |
| Cash And Equivalents | 22.77 M | 2.7 B |
| Cash Per Share | 1.29 X | 5.01 X |
| Debt To Equity | 1.20 % | 48.70 % |
| Current Ratio | 9.56 X | 2.16 X |
| Book Value Per Share | 0.20 X | 1.93 K |
| Cash Flow From Operations | (45.02 M) | 971.22 M |
| Earnings Per Share | (0.43) X | 3.12 X |
| Target Price | 2.0 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | 1.55 | -0.15 |
| Market Capitalization | 189.95 M | 19.03 B |
| Total Asset | 52.79 M | 29.47 B |
| Net Asset | 52.79 M |
Annexin Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Annexin . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Annexin Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Annexin Pharmaceuticals AB? Buying financial instruments such as Annexin Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Annexin Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hedge Favorites Thematic Idea Now
Hedge Favorites
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.